Vici, P., Sperati, F., Maugeri-Saccà, M., Melucci, E., Benedetto, A. D., Lauro, L. D., . . . Barba, M. (2014). p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab. Oncotarget.
シカゴスタイル引用形Vici, Patrizia, et al. "P53 Status As Effect Modifier of the Association between Pre-treatment Fasting Glucose and Breast Cancer Outcomes in Non Diabetic, HER2 Positive Patients Treated With Trastuzumab." Oncotarget 2014.
MLA引用形式Vici, Patrizia, et al. "P53 Status As Effect Modifier of the Association between Pre-treatment Fasting Glucose and Breast Cancer Outcomes in Non Diabetic, HER2 Positive Patients Treated With Trastuzumab." Oncotarget 2014.